Antonio Curotto

482 total citations
28 papers, 358 citations indexed

About

Antonio Curotto is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Antonio Curotto has authored 28 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Antonio Curotto's work include Bladder and Urothelial Cancer Treatments (22 papers), Urinary and Genital Oncology Studies (11 papers) and Renal cell carcinoma treatment (6 papers). Antonio Curotto is often cited by papers focused on Bladder and Urothelial Cancer Treatments (22 papers), Urinary and Genital Oncology Studies (11 papers) and Renal cell carcinoma treatment (6 papers). Antonio Curotto collaborates with scholars based in Italy, United Kingdom and United States. Antonio Curotto's co-authors include Andrea DeCensi, Francesco Boccardo, Silvia Bruno, Luciano Canobbio, Domenico Guarneri, Rosalba Torrisi, Paolo Bruzzi, Guido Nicolò, Beatrice Gatteschi and Giuseppe Martorana and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Antonio Curotto

25 papers receiving 345 citations

Peers

Countries citing papers authored by Antonio Curotto

Since Specialization

Citations

This map shows the geographic impact of Antonio Curotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Curotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Curotto more than expected).

Fields of papers citing papers by Antonio Curotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Curotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Curotto. The network helps show where Antonio Curotto may publish in the future.

Co-authorship network of co-authors of Antonio Curotto

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Curotto. A scholar is included among the top collaborators of Antonio Curotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Curotto. Antonio Curotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non–Muscle-Invasive Bladder Cancer 2016 ·Cancer Prevention Research ·Matteo Puntoni, Marilena Petrera, (unknown), Elsa Garrone, Carlotta Defferrari, Rosalba Torrisi, Harriet Johansson, Silvia Bruno, Antonio Curotto, Andrea DeCensi	20
2	[Early vs delayed radical cystectomy compared in highgrade superficial bladder tumors]. 2015 ·PubMed ·Virginia Varca, Alchiede Simonato, Maria Valeria Esposito, Antonio Curotto, (unknown), (unknown)	1
3	Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study 2010 ·Urologia Internationalis ·Paolo Gontero, Marco Oderda, Vincenzo Altieri, Riccardo Bartoletti, Tommaso Cai, Renzo Colombo, Antonio Curotto, Savino M. Di Stasi, Massimo Maffezzini, (unknown), Vincenzo Serretta, Filippo Sogni, Carlo Terrone, A Tizzani, Giuseppe Morgia, Vincenzo Mirone, G. Carmignani	23
4	Early vs Delayed Radical Cystectomy Compared in Highgrade Superficial Bladder Tumors 2009 ·Urologia Journal ·Virginia Varca, Alchiede Simonato, Maria Valeria Esposito, Antonio Curotto, (unknown), (unknown), G. Carmignani	0
5	Pre and postoperative quantitative detection of fragments of cytokeratins 8 and 18 (UBC IRMA) as markers of early recurrence of superficial bladder tumor. 2006 ·PubMed ·Mauro Gacci, Sergio Serni, Alberto Lapini, Gianluca Giubilei, (unknown), (unknown), Antonio Curotto, Fabrizio Gallo, G. Carmignani, Marco Carini	2
6	Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial 2000 ·Journal of Cellular Biochemistry ·Silvia Bruno, Rosalba Torrisi, Massimo Costantini, Laura Baglietto, Vincenzo Fontana, Beatrice Gatteschi, Giovanni Melioli, Guido Nicolò, Antonio Curotto, (unknown), (unknown), (unknown), Paolo Bruzzi, Andrea DeCensi	10
7	Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapy. 1997 ·PubMed ·Giuseppe Sanguineti, (unknown), Maria Pia Sormani, Luciano Canobbio, Antonio Curotto, Piero Tognoni, (unknown), P. Franzone, Francesco Boccardo, Vito Vitale	3
8	Intravesical idarubicin: a dose-finding study 1996 ·Cancer Chemotherapy and Pharmacology ·Francesco Boccardo, D Cannata, (unknown), Maurizio Schenone, Antonio Curotto	3
9	Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer 1996 ·Cancer Immunology Immunotherapy ·Silvia Bruno, (unknown), Claudia Semino, (unknown), Marco Ponte, (unknown), Antonio Curotto, Guido Ferlazzo, Andrea DeCensi, Giovanni Melioli	14
10	Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-? 1995 ·Journal of Cancer Research and Clinical Oncology ·Luciano Canobbio, A. Rubagotti, Loredana Miglietta, (unknown), Antonio Curotto, D. Amoroso, Francesco Boccardo	14
11	Alternating chemo-radiotherapy in bladder cancer: A conservative approach 1995 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Antonio Curotto, Luciano Canobbio, Domenico Guarneri, D Scarpati, Marco Venturini, P. Franzone, (unknown), Giuseppe Martorana, Francesco Boccardo, Luciano Giuliani, Vito Vitale	28
12	Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial 1994 ·Cancer ·Francesco Boccardo, (unknown), Domenico Guarneri, Luciano Canobbio, Antonio Curotto, Giuseppe Martorana	21
13	Phase IIa Study of Fenretinide in Superficial Bladder Cancer, Using DNA Flow Cytometry as an Intermediate End Point 1994 ·JNCI Journal of the National Cancer Institute ·Andrea DeCensi, Silvia Bruno, Massimo Costantini, Rosalba Torrisi, Antonio Curotto, Beatrice Gatteschi, Guido Nicolò, Alessandro Polizzi, Michael Perloff, Winfred F. Malone, Paolo Bruzzi	52
14	Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study. 1994 ·Journal of Clinical Oncology ·Francesco Boccardo, (unknown), A. Rubagotti, Domenico Guarneri, Andrea DeCensi, Luciano Canobbio, Antonio Curotto, G. Martorana, (unknown), Francesco Paolo Selvaggi	38
15	DNA flow cytometry as a surrogate end-point in patients with superficial bladder cancer treated with 4-HPR 1994 ·European Journal of Cancer Prevention ·Andrea DeCensi, Antonio Curotto, Silvia Bruno, Massimo Costantini, Rosalba Torrisi, Beatrice Gatteschi, (unknown), (unknown), (unknown), (unknown), Monica Schenone, (unknown), Paolo Bruzzi	2
16	Activity of 4-HPR in superficial bladder caner using DNA flow cytometry as an intermediate endpoint 1992 ·Journal of Cellular Biochemistry ·Andrea DeCensi, Silvia Bruno, Walter Giaretti, Rosalba Torrisi, Antonio Curotto, Beatrice Gatteschi, Elio Geido, (unknown), Massimo Costantini, Paolo Bruzzi, Guido Nicolò, Alberto Costa, Francesco Boccardo, (unknown), Leonardo Santi	20
17	Neoadjuvant or Definitive Alternating Chemotherapy and Radiotherapy for Infiltrating Bladder Cancer 1989 ·American Journal of Clinical Oncology ·Marco Venturini, Marco Merlano, Andrea Michelotti, Giuseppe Martorana, Antonio Curotto, D Scarpati, (unknown), Luciano Giuliani, Riccardo Rosso	12
18	Recombinant α-2a Interferon Plus Vinblastine in the Treatment of Metastatic Renal Cell Carcinoma 1989 ·American Journal of Clinical Oncology ·(unknown), I. Brunetti, Andrea Ardizzoni, Alfredo Falcone, Domenico Guarneri, Francesco Boccardo, (unknown), Antonio Curotto, A. Sicignano, Riccardo Rosso, (unknown)	14
19	Treatment of urinary tract infections with ciprofloxacin. 1988 ·PubMed ·Giuseppe Martorana, Claudio Giberti, (unknown), (unknown), Fabrizio Oneto, Antonio Curotto, (unknown)	4
20	Successful Extraction of Renal Cell Carcinoma ThrombusExtending into the Right Atrium Using Extracorporeal Circulation,Profound Hypothermia and Cardiac Arrest 1987 ·European Urology ·Luciano Giuliani, Giuseppe Martorana, Claudio Giberti, (unknown), (unknown), Antonio Curotto	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact